Marino Garcia, Dianthus Therapeutics CEO

Di­anthus teas­es pre­clin­i­cal da­ta for au­toim­mune drug as it starts clin­i­cal tri­als

Di­anthus Ther­a­peu­tics has un­veiled in vit­ro re­sults of its drug can­di­date in a pair of au­toim­mune dis­ease mod­els, sup­port­ing re­cent ef­forts to start mid-stage stud­ies …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.